David A. Hyman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
David A. Hyman has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Charles Silver
4 shared publications- Mohammad Hossein Rahmati
Sharif University of Technology
2 shared publications Bernard Black
1 shared publicationBernard S. Black
1 shared publicationDavid M. Studdert
Center for Health Policy, Stanford University School of Medicine, and Stanford Law School, Stanford, CA
1 shared publication
Latest Publications
- 17 November 2016
- Published by Wiley in Journal of Empirical Legal Studies
- Vol. 13 (4) , 603-636
Medical Malpractice Litigation and the Market for Plaintiff‐Side Representation: Evidence from Illinois
How concentrated is the market for medical malpractice (med mal) legal representation? Do successful plaintiffs’ lawyers start off with better cases to begin with, do they add more value to the cases they handle, or both? How do top plaintiffs’ lawyers market their services, and where did they go to school? How large are the “wages of risk”—the compensation to plaintiffs’ lawyers for working on contingency? How often do plaintiffs proceed pro se, and with what results? We address these questions using a data set of every insured med mal case closed in Illinois during 2000–2010. We show that most plaintiffs have a lawyer. We quantify the market share, case mix, and amounts recovered by the 1,317 law firms that handled med mal cases in our sample, stratify the firms into four tiers, and assess differences across tiers. We find that the market for plaintiff‐side med mal representation is both unconcentrated and highly stratified. At all firms, a small number of cases account for a heavily disproportionate share of total recoveries. We use the extensive covariates in our data to (imperfectly) address sample selection, and to estimate the effect of having a lawyer and law firm tier on outcomes. Controlling for observable claim characteristics, having a lawyer predicts a large increase in the probability of prevailing and the estimated recovery. Higher‐tier firms have only modestly higher success rates, but substantially higher estimated recoveries. However, the differences shrink and are statistically insignificant when we compare first‐tier to second‐tier firms. This suggests that there are substantial benefits to having a lawyer—and a higher‐tier lawyer—but diminishing marginal returns at the top of the market. Assuming that there is some unobserved case selection, our findings provide a plausible upper bound on the “value added” by different tiers of plaintiffs’ lawyers.
- 17 November 2016
- Published by Wiley in Journal of Empirical Legal Studies
- Vol. 13 (4) , 603-636
Medical Malpractice Litigation and the Market for Plaintiff‐Side Representation: Evidence from Illinois
How concentrated is the market for medical malpractice (med mal) legal representation? Do successful plaintiffs’ lawyers start off with better cases to begin with, do they add more value to the cases they handle, or both? How do top plaintiffs’ lawyers market their services, and where did they go to school? How large are the “wages of risk”—the compensation to plaintiffs’ lawyers for working on contingency? How often do plaintiffs proceed pro se, and with what results? We address these questions using a data set of every insured med mal case closed in Illinois during 2000–2010. We show that most plaintiffs have a lawyer. We quantify the market share, case mix, and amounts recovered by the 1,317 law firms that handled med mal cases in our sample, stratify the firms into four tiers, and assess differences across tiers. We find that the market for plaintiff‐side med mal representation is both unconcentrated and highly stratified. At all firms, a small number of cases account for a heavily disproportionate share of total recoveries. We use the extensive covariates in our data to (imperfectly) address sample selection, and to estimate the effect of having a lawyer and law firm tier on outcomes. Controlling for observable claim characteristics, having a lawyer predicts a large increase in the probability of prevailing and the estimated recovery. Higher‐tier firms have only modestly higher success rates, but substantially higher estimated recoveries. However, the differences shrink and are statistically insignificant when we compare first‐tier to second‐tier firms. This suggests that there are substantial benefits to having a lawyer—and a higher‐tier lawyer—but diminishing marginal returns at the top of the market. Assuming that there is some unobserved case selection, our findings provide a plausible upper bound on the “value added” by different tiers of plaintiffs’ lawyers.
- 11 May 2016
- Published by Wiley in Journal of Empirical Legal Studies
- Vol. 13 (2) , 183-204
Insurance Crisis or Liability Crisis? Medical Malpractice Claiming in Illinois, 1980–2010
- 11 May 2016
- Published by Wiley in Journal of Empirical Legal Studies
- Vol. 13 (2) , 183-204
Insurance Crisis or Liability Crisis? Medical Malpractice Claiming in Illinois, 1980–2010
- Open Access
- 1 April 2009
- Published by Elsevier in SSRN Electronic Journal
- Vol. 9 (2) , 435-52
Employment-Based Health Insurance and Universal Coverage: Four Things People Know That Aren't So
Employment-based health insurance is the Rodney Dangerfield of U.S. health policy: it gets no respect from anyone. Employment-based coverage ("EBC") may not get much respect, but it covers roughly 177 million people - and it appears to have considerable staying power - even if the principal explanation for that staying power is nothing more compelling than inertia. Given the likely prevalence of EBC for the foreseeable future, it is worth emphasizing four important points about EBC and universal coverage. What these points have in common is that they are myths - most people believe they are true, even though they are not. The four "myths" are these: * Employers pay for EBC; * There are 45.7 million uninsured Americans; * Universal coverage means everyone will have access to high quality care; * Universal coverage will solve the cost problems of American health care. The paper explains why each of these points are "things people know that aren't so." It then highlights the budgetary and collective action problems with trying to get to universal coverage without relying on EBC, at least for the foreseeable future.
- 1 April 2009
- Published by Elsevier in SSRN Electronic Journal
- Vol. 9 (2) , 435-52
Open AccessEmployment-Based Health Insurance and Universal Coverage: Four Things People Know That Aren't So
Employment-based health insurance is the Rodney Dangerfield of U.S. health policy: it gets no respect from anyone. Employment-based coverage ("EBC") may not get much respect, but it covers roughly 177 million people - and it appears to have considerable staying power - even if the principal explanation for that staying power is nothing more compelling than inertia. Given the likely prevalence of EBC for the foreseeable future, it is worth emphasizing four important points about EBC and universal coverage. What these points have in common is that they are myths - most people believe they are true, even though they are not. The four "myths" are these: * Employers pay for EBC; * There are 45.7 million uninsured Americans; * Universal coverage means everyone will have access to high quality care; * Universal coverage will solve the cost problems of American health care. The paper explains why each of these points are "things people know that aren't so." It then highlights the budgetary and collective action problems with trying to get to universal coverage without relying on EBC, at least for the foreseeable future.